Brain peroxisomes

Biochimie

Volumn 98, Issue 1, 2014, Pages 102-110

  Trompier, D ^a   Vejux, A ^a   Zarrouk, A ^a,b   Gondcaille, C ^a   Geillon, F ^a   Nury, T ^a   Savary, S ^a   Lizard, G ^a  

^a Faculté des Sciences Gabriel   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Alzheimer's disease; Demyelination; Inflammation; Oxidative stress; Peroxisome disorders

Indexed keywords

AGING; ALZHEIMER DISEASE; BIOGENESIS; BRAIN; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; BRAIN MALFORMATION; CALCIUM HOMEOSTASIS; CELL DEATH; CELL FUNCTION; CELL MIGRATION; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DEMYELINATION; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME DEFECT; FATTY ACID OXIDATION; GENE EXPRESSION; HUMAN; INFLAMMATION; LEUKODYSTROPHY; METABOLISM; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PEROXISOME; REVIEW; ZELLWEGER SYNDROME;

EUKARYOTA;

ALZHEIMER'S DISEASE; DEMYELINATION; INFLAMMATION; OXIDATIVE STRESS; PEROXISOME DISORDERS;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; DEMYELINATING DISEASES; ENCEPHALITIS; HUMANS; MICE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PEROXISOMAL DISORDERS; PEROXISOMES;

EID: 84895164102     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.09.009     Document Type: Short Survey

References (85)

1. M. Islinger, S. Grille, H.D. Fahimi, and M. Schrader The peroxisome: an update on mysteries Histochem. Cell Biol. 137 2012 547 574
2. N. Troffer-Charlier, N. Doerflinger, E. Metzger, F. Fouquet, J.L. Mandel, and P. Aubourg Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines Eur. J. Cell. Biol. 75 1998 254 264
3. M. Schrader, M. Thiemann, and H.D. Fahimi Peroxisomal motility and interaction with microtubules Microsc. Res. Tech. 61 2003 171 178
4. J. Mathur, N. Mathur, and M. Hulskamp Simultaneous visualization of peroxisomes and cytoskeletal elements reveals actin and not microtubule-based peroxisome motility in plants Plant Physiol. 128 2002 1031 1045
5. M. Fransen, M. Nordgren, B. Wang, and O. Apanasets Role of peroxisomes in ROS/RNS-metabolism: implications for human disease Biochim. Biophys. Acta 1822 2012 1363 1373
6. R.J. Wanders, and H.R. Waterham Biochemistry of mammalian peroxisomes revisited Annu. Rev. Biochem. 75 2006 295 332
7. R.S. Chapkin, W. Kim, J.R. Lupton, and D.N. McMurray Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation Prostaglandins Leukot. Essent. Fatty Acids 81 2009 187 191
8. S. Ferdinandusse, S. Denis, P.A. Mooijer, Z. Zhang, J.K. Reddy, A.A. Spector, and R.J. Wanders Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid J. Lipid Res. 42 2001 1987 1995
9. N. Salem Jr., B. Litman, H.Y. Kim, and K. Gawrisch Mechanisms of action of docosahexaenoic acid in the nervous system Lipids 36 2001 945 959
10. A.A. Farooqui n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation Curr. Med. Chem. 19 2012 532 543
11. A.A. Farooqui, L.A. Horrocks, and T. Farooqui Modulation of inflammation in brain: a matter of fat J. Neurochem. 101 2007 577 599
12. S.I. Rapoport, M. Igarashi, and F. Gao Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis Prostaglandins Leukot. Essent. Fatty Acids 82 2010 273 276
13. P. Brites, H.R. Waterham, and R.J. Wanders Functions and biosynthesis of plasmalogens in health and disease Biochim. Biophys. Acta 1636 2004 219 231
14. H. Hayashi, and M. Hara 1-Alkenyl group of ethanolamine plasmalogen derives mainly from de novo-synthesized fatty alcohol within peroxisomes, but not extraperoxisomal fatty alcohol or fatty acid J. Biochem. 121 1997 978 983
15. N.E. Braverman, and A.B. Moser Functions of plasmalogen lipids in health and disease Biochim. Biophys. Acta 1822 2012 1442 1452
16. P.A. Loughran, D.B. Stolz, S.R. Barrick, D.S. Wheeler, P.A. Friedman, R.A. Rachubinski, S.C. Watkins, and T.R. Billiar PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes Nitric Oxide 31 2013 9 19
17. L.A. Del Rio Peroxisomes as a cellular source of reactive nitrogen species signal molecules Arch. Biochem. Biophys. 506 2011 1 11
18. H.R. Waterham, and M.S. Ebberink Genetics and molecular basis of human peroxisome biogenesis disorders Biochim. Biophys. Acta 1822 2012 1430 1441
19. S.J. Steinberg, G. Dodt, G.V. Raymond, N.E. Braverman, A.B. Moser, and H.W. Moser Peroxisome biogenesis disorders Biochim. Biophys. Acta 1763 2006 1733 1748
20. R. Wilson, and J.R. Sargent Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients J. Neurochem. 61 1993 290 297
21. F. Geillon, D. Trompier, C. Gondcaille, G. Lizard, and S. Savary Peroxisomal ABC transporters and X-linked adrenoleukodystrophy Med. Sci. (Paris) 28 2012 1087 1094
22. C. Wiesinger, M. Kunze, G. Regelsberger, S. Forss-Petter, and J. Berger Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction J. Biol. Chem. 288 2013 19269 19279
23. J.M. Powers, and H.W. Moser Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis Brain Pathol. 8 1998 101 120
24. P.L. Faust, D. Banka, R. Siriratsivawong, V.G. Ng, and T.M. Wikander Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain J. Inherit. Metab. Dis. 28 2005 369 383
25. S. Ferdinandusse, S. Denis, P.A. Mooyer, C. Dekker, M. Duran, R.J. Soorani-Lunsing, E. Boltshauser, A. Macaya, J. Gartner, C.B. Majoie, P.G. Barth, R.J. Wanders, and B.T. Poll-The Clinical and biochemical spectrum of D-bifunctional protein deficiency Ann. Neurol. 59 2006 92 104
26. W.E. Kaufmann, C. Theda, S. Naidu, P.A. Watkins, A.B. Moser, and H.W. Moser Neuronal migration abnormality in peroxisomal bifunctional enzyme defect Ann. Neurol. 39 1996 268 271
27. R.I. Kelley, N.S. Datta, W.B. Dobyns, A.K. Hajra, A.B. Moser, M.J. Noetzel, E.H. Zackai, and H.W. Moser Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes Am. J. Med. Genet. 23 1986 869 901
28. A. Janssen, P. Gressens, M. Grabenbauer, E. Baumgart, A. Schad, I. Vanhorebeek, A. Brouwers, P.E. Declercq, D. Fahimi, P. Evrard, L. Schoonjans, D. Collen, P. Carmeliet, G. Mannaerts, P. Van Veldhoven, and M. Baes Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues J. Neurosci. 23 2003 9732 9741
29. M. Baes, and P. Aubourg Peroxisomes, myelination, and axonal integrity in the CNS Neuroscientist 15 2009 367 379
30. A.J. Barkovich, and W.W. Peck MR of Zellweger syndrome AJNR Am. J. Neuroradiol. 18 1997 1163 1170
31. P.G. Barth, C.B. Majoie, J. Gootjes, R.J. Wanders, H.R. Waterham, M.S. van der Knaap, J.B. de Klerk, J. Smeitink, and B.T. Poll-The Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival Neurology 62 2004 439 444
32. A.M. Bams-Mengerink, C.B. Majoie, M. Duran, R.J. Wanders, J. Van Hove, C.D. Scheurer, P.G. Barth, and B.T. Poll-The MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata Neurology 66 2006 798 803
33. S. Ferdinandusse, M.S. Ylianttila, J. Gloerich, M.K. Koski, W. Oostheim, H.R. Waterham, J.K. Hiltunen, R.J. Wanders, and T. Glumoff Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype-phenotype analysis Am. J. Hum. Genet. 78 2006 112 124
34. D. Trompier, and S. Savary X-linked Adrenoleukodystrophy, Morgan & Claypool Life Sciences vol. 2 2013 1 134
35. R. Chrast, G. Saher, K.A. Nave, and M.H. Verheijen Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models J. Lipid Res. 52 2011 419 434
36. N. Baumann, and D. Pham-Dinh Biology of oligodendrocyte and myelin in the mammalian central nervous system Physiol. Rev. 81 2001 871 927
37. J.K. Ho, H. Moser, Y. Kishimoto, and J.A. Hamilton Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy J. Clin. Invest. 96 1995 1455 1463
38. M. Baarine, P. Andreoletti, A. Athias, T. Nury, A. Zarrouk, K. Ragot, A. Vejux, J.M. Riedinger, Z. Kattan, G. Bessede, D. Trompier, S. Savary, M. Cherkaoui-Malki, and G. Lizard Evidence of oxidative stress in very long chain fatty acid - treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins Neuroscience 213 2012 1 18
39. S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture Hum. Mol. Genet. 17 2008 1750 1761
40. A. Bottelbergs, S. Verheijden, L. Hulshagen, D.H. Gutmann, S. Goebbels, K.A. Nave, C. Kassmann, and M. Baes Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes Glia 58 2010 1532 1543
41. J.M. Powers, Y. Liu, A.B. Moser, and H.W. Moser The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications J. Neuropathol. Exp. Neurol. 51 1992 630 643
42. M.C. McGuinness, D.E. Griffin, G.V. Raymond, C.A. Washington, H.W. Moser, and K.D. Smith Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy J. Neuroimmunol. 61 1995 161 169
43. J.M. Powers The pathology of peroxisomal disorders with pathogenetic considerations J. Neuropathol. Exp. Neurol. 54 1995 710 719
44. A.S. Paintlia, A.G. Gilg, M. Khan, A.K. Singh, E. Barbosa, and I. Singh Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies Neurobiol. Dis. 14 2003 425 439
45. C.M. Kassmann, C. Lappe-Siefke, M. Baes, B. Brugger, A. Mildner, H.B. Werner, O. Natt, T. Michaelis, M. Prinz, J. Frahm, and K.A. Nave Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes Nat. Genet. 39 2007 969 976
46. A. Bottelbergs, S. Verheijden, P.P. Van Veldhoven, W. Just, R. Devos, and M. Baes Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system J. Neuroinflamm. 9 2012 61
47. F.D. Mast, J. Li, M.K. Virk, S.C. Hughes, A.J. Simmonds, and R.A. Rachubinski A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders Dis. Model Mech. 4 2011 659 672
48. E. Galea, N. Launay, M. Portero-Otin, M. Ruiz, R. Pamplona, P. Aubourg, I. Ferrer, and A. Pujol Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim. Biophys. Acta 1822 2012 1475 1488
49. M. Khan, J. Singh, A.G. Gilg, T. Uto, and I. Singh Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy J. Lipid Res. 51 2010 1685 1695
50. I. Singh, and A. Pujol Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis Brain Pathol. 20 2010 838 844
51. O. Ivashchenko, P.P. Van Veldhoven, C. Brees, Y.S. Ho, S.R. Terlecky, and M. Fransen Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk Mol. Biol. Cell 22 2011 1440 1451
52. J.M. Powers, Z. Pei, A.K. Heinzer, R. Deering, A.B. Moser, H.W. Moser, P.A. Watkins, and K.D. Smith Adreno-leukodystrophy: oxidative stress of mice and men J. Neuropathol. Exp. Neurol. 64 2005 1067 1079
53. B. Ahlemeyer, M. Gottwald, and E. Baumgart-Vogt Deletion of a single allele of the Pex11beta gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain Dis. Model Mech. 5 2012 125 140
54. C.C. Muller, T.H. Nguyen, B. Ahlemeyer, M. Meshram, N. Santrampurwala, S. Cao, P. Sharp, P.B. Fietz, E. Baumgart-Vogt, and D.I. Crane PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress Dis. Model Mech. 4 2011 104 119
55. M. Baarine, K. Ragot, A. Athias, T. Nury, Z. Kattan, E.C. Genin, P. Andreoletti, F. Menetrier, J.M. Riedinger, M. Bardou, and G. Lizard Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-alpha on oligodendrocytes and astrocytes Neurotoxicology 33 2012 212 228
56. I. Singh, K. Pahan, M. Khan, and A.K. Singh Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases J. Biol. Chem. 273 1998 20354 20362
57. V. Feigenbaum, A. Gelot, P. Casanova, C. Daumas-Duport, P. Aubourg, and M. Dubois-Dalcq Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients Neurobiol. Dis. 7 2000 600 612
58. F.S. Eichler, J.Q. Ren, M. Cossoy, A.M. Rietsch, S. Nagpal, A.B. Moser, M.P. Frosch, and R.M. Ransohoff Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann. Neurol. 63 2008 729 742
59. M. Ito, B.M. Blumberg, D.J. Mock, A.D. Goodman, A.B. Moser, H.W. Moser, K.D. Smith, and J.M. Powers Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation J. Neuropathol. Exp. Neurol. 60 2001 1004 1019
60. E. Kahn, M. Baarine, A. Dauphin, K. Ragot, N. Tissot, A. Seguin, F. Menetrier, Z. Kattan, C.M. Bachelet, F. Frouin, and G. Lizard Impact of 7-ketocholesterol and very long chain fatty acids on oligodendrocyte lipid membrane organization: evaluation via LAURDAN and FAMIS spectral image analysis Cytometry A 79 2011 293 305
61. A. Zarrouk, A. Vejux, T. Nury, H.I. El Hajj, M. Haddad, M. Cherkaoui-Malki, J.M. Riedinger, M. Hammami, and G. Lizard Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E) Oxid. Med. Cell. Longev. 2012 2012 623257
62. C.R. Giordano, and S.R. Terlecky Peroxisomes, cell senescence, and rates of aging Biochim. Biophys. Acta 1822 2012 1358 1362
63. L. Goth, and J.W. Eaton Hereditary catalase deficiencies and increased risk of diabetes Lancet 356 2000 1820 1821
64. C.S. Wood, J.I. Koepke, H. Teng, K.K. Boucher, S. Katz, P. Chang, L.J. Terlecky, I. Papanayotou, P.A. Walton, and S.R. Terlecky Hypocatalasemic fibroblasts accumulate hydrogen peroxide and display age-associated pathologies Traffic 7 2006 97 107
65. J.I. Koepke, C.S. Wood, L.J. Terlecky, P.A. Walton, and S.R. Terlecky Progeric effects of catalase inactivation in human cells Toxicol. Appl. Pharmacol. 232 2008 99 108
66. A. Beach, M.T. Burstein, V.R. Richard, A. Leonov, S. Levy, and V.I. Titorenko Integration of peroxisomes into an endomembrane system that governs cellular aging Front. Physiol. 3 2012 283
67. E.B. Aksam, A. Koek, J.A. Kiel, S. Jourdan, M. Veenhuis, and I.J. van der Klei A peroxisomal lon protease and peroxisome degradation by autophagy play key roles in vitality of Hansenula polymorpha cells Autophagy 3 2007 96 105
68. J.E. Legakis, J.I. Koepke, C. Jedeszko, F. Barlaskar, L.J. Terlecky, H.J. Edwards, P.A. Walton, and S.R. Terlecky Peroxisome senescence in human fibroblasts Mol. Biol. Cell 13 2002 4243 4255
69. M.W. Marlatt, and P.J. Lucassen Neurogenesis and Alzheimer's disease: biology and pathophysiology in mice and men Curr. Alzheimer Res. 7 2010 113 125
70. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
71. V.I. Titorenko, and S.R. Terlecky Peroxisome metabolism and cellular aging Traffic 12 2011 252 259
72. D.L. Marcus, C. Thomas, C. Rodriguez, K. Simberkoff, J.S. Tsai, J.A. Strafaci, and M.L. Freedman Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease Exp. Neurol. 150 1998 40 44
73. D.B. Goodenowe, L.L. Cook, J. Liu, Y. Lu, D.A. Jayasinghe, P.W. Ahiahonu, D. Heath, Y. Yamazaki, J. Flax, K.F. Krenitsky, D.L. Sparks, A. Lerner, R.P. Friedland, T. Kudo, K. Kamino, T. Morihara, M. Takeda, and P.L. Wood Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia J. Lipid Res. 48 2007 2485 2498
74. S. Manivannan, C.Q. Scheckhuber, M. Veenhuis, and I.J. van der Klei The impact of peroxisomes on cellular aging and death Front. Oncol. 2 2012 50
75. J. Lopez-Erauskin, I. Ferrer, E. Galea, and A. Pujol Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case Biol. Chem. 394 2013 621 629
76. S.R. Terlecky, J.I. Koepke, and P.A. Walton Peroxisomes and aging Biochim. Biophys. Acta 1763 2006 1749 1754
77. G. Lizard, O. Rouaud, J. Demarquoy, M. Cherkaoui-Malki, and L. Iuliano Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type J. Alzheimers Dis. 29 2012 241 254
78. M.J. Santos, R.A. Quintanilla, A. Toro, R. Grandy, M.C. Dinamarca, J.A. Godoy, and N.C. Inestrosa Peroxisomal proliferation protects from beta-amyloid neurodegeneration J. Biol. Chem. 280 2005 41057 41068
79. A. Cimini, S. Moreno, M. D'Amelio, L. Cristiano, B. D'Angelo, S. Falone, E. Benedetti, P. Carrara, F. Fanelli, F. Cecconi, F. Amicarelli, and M.P. Ceru Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes J. Alzheimers Dis. 2009
80. F. Fanelli, S. Sepe, M. D'Amelio, C. Bernardi, L. Cristiano, A. Cimini, F. Cecconi, M.P. Ceru, and S. Moreno Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease Mol. Neurodegener. 8 2013 8
81. R. Shi, Y. Zhang, Y. Shi, S. Shi, and L. Jiang Inhibition of peroxisomal beta-oxidation by thioridazine increases the amount of VLCFAs and Abeta generation in the rat brain Neurosci. Lett. 528 2012 6 10
82. M. Igarashi, K. Ma, F. Gao, H.W. Kim, S.I. Rapoport, and J.S. Rao Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex J. Alzheimers Dis. 24 2011 507 517
83. P.L. Wood, R. Mankidy, S. Ritchie, D. Heath, J.A. Wood, J. Flax, and D.B. Goodenowe Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients J. Psychiatry Neurosci. 35 2010 59 62
84. J. Kou, G.G. Kovacs, R. Hoftberger, W. Kulik, A. Brodde, S. Forss-Petter, S. Honigschnabl, A. Gleiss, B. Brugger, R. Wanders, W. Just, H. Budka, S. Jungwirth, P. Fischer, and J. Berger Peroxisomal alterations in Alzheimer's disease Acta Neuropathol. 122 2011 271 283
85. G. Astarita, K.M. Jung, N.C. Berchtold, V.Q. Nguyen, D.L. Gillen, E. Head, C.W. Cotman, and D. Piomelli Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease PLoS One 5 2010 e12538